Theraclion SA (EPA:ALTHE)
0.5000
-0.0100 (-1.96%)
At close: Mar 13, 2026
Theraclion Market Cap
Theraclion has a market cap or net worth of €23.49 million as of March 13, 2026. Its market cap has increased by 165.09% in one year.
Market Cap
23.49M
Enterprise Value
26.90M
Revenue
1.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.50
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 23.49M, a decrease of -37.41%. That is a compound annual growth rate of -3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 23.49M | -16.94% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 176.15M |
| Guerbet | 111.39M |
| Diagnostic Medical Systems | 32.89M |
| Implanet | 27.51M |
| Novacyt | 27.08M |
| Ikonisys | 23.29M |
| Mauna Kea Technologies | 19.92M |
| Biosynex | 16.01M |